Atlas Trials

Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET

Clinical trial NCT06758882 · RECRUITING

Trial details

NCT number
NCT06758882
Sponsor
Marco Oderda
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
High Risk Prostate Cancer
Start date
2024-11-25
Primary completion
2026-01-01
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.